Yes. Radiation can make you lose your hair, but only when the beam passes through skin containing hair follicles at a dose high enough to injure the follicle's dividing cells. Hair loss from radiation is called radiation alopecia. It is usually confined to the treatment field, often begins one to three weeks after the first session, and is frequently temporary at lower doses. Whether hair regrows depends on dose, fractionation, scalp location, and whether the follicle's stem-cell reservoir survives.

The mechanism is not mystery. Hair is one of the most rapidly dividing tissues in the body, and radiation preferentially damages rapidly dividing cells. That single fact explains why scalp hair falls out during cranial radiation, why armpit and chest hair can thin during breast treatment, and why a course aimed at the prostate almost never affects the head.

Mechanism: Why Fast-Dividing Follicles Fail

Each hair follicle cycles through three phases. Anagen is active growth, when matrix cells above the dermal papilla divide rapidly and push a growing hair shaft upward. Catagen is a short transition. Telogen is rest.

Radiation does its damage during anagen. Ionizing photons or particles strike DNA and water molecules in follicle cells. Direct DNA breaks and indirect damage from reactive oxygen species overwhelm repair enzymes. Cells with unrepaired double-strand breaks arrest in the cell cycle or die by apoptosis. The hair matrix is packed with such cells, so the shaft loses its manufacturing base.

The follicle does not fall out immediately. Keratinized hair is dead tissue. What happens is that the growing hair narrows into a fragile, dysplastic shaft, then detaches at the bulb weeks later. That lag explains the typical delay between exposure and shedding.

A second population matters just as much. Bulge stem cells, located near the arrector pili muscle attachment, cycle slowly and are relatively radioresistant. They are the reservoir for regrowth. When dose is modest, bulge cells survive, migrate down, and rebuild the matrix. When dose is high enough to sterilize the stem-cell compartment, regrowth fails.

Fractionation changes the arithmetic. Dividing a total dose into many small fractions allows surviving cells to repair sublethal damage between sessions. A single 8 Gy exposure and forty 0.5 Gy fractions do not produce the same follicle outcome, even though the total is similar. This is why clinical prediction uses biologically effective dose, not raw gray alone.

One plain-language version: hair loss happens because radiation breaks the hair factory's fast-dividing workers, and regrowth depends on whether the slower stem-cell foremen survive the shift.

Quantified Context: Doses, Timing, and Thresholds

Radiation alopecia follows a dose-response curve. Several thresholds circulate in clinical literature, and they must be reconciled rather than quoted loosely.

Epilation, meaning loss of hair, is generally reported to begin at single doses around 2 to 3 Gy to the scalp. Permanent loss is associated with higher exposure, often cited in the range of 5 to 7 Gy single dose or biologically equivalent fractionated schedules. Temporary thinning is common at lower cumulative doses.

These numbers describe the scalp specifically. Follicle density and sensitivity vary by body site, so a chest-wall dose that thins axillary hair may leave scalp hair untouched.

The chart below summarizes commonly cited scalp exposure ranges and expected outcomes. Values are approximate and drawn from radiation oncology literature rather than a single trial.

Scalp dose (approximate) Typical outcome Regrowth expectation
Under 2 Gy single dose Minimal or no visible loss Full
2 to 3 Gy single dose Patchy loss within weeks Usually full
3 to 5 Gy single dose Marked loss in field Often partial to full
5 to 7 Gy single dose High risk of lasting loss Uncertain; specialist assessment
Fractionated cranial courses Field-limited thinning or loss Variable, dose-dependent
Whole-brain palliative courses Diffuse thinning possible Often partial
Very high focal doses Permanent alopecia in field Limited

Fractionated schedules require separate interpretation. A patient receiving 30 Gy in 10 fractions to a scalp lesion and a patient receiving 30 Gy in 30 fractions are not equivalent. The higher dose per fraction carries more biologic effect on late-responding and stem-cell populations.

Timing is fairly consistent. Shedding typically starts 1 to 3 weeks after the first fraction and peaks around 2 to 4 weeks. Regrowth, when it occurs, usually begins 1 to 3 months after treatment ends. Full cosmetic recovery may take six months or longer, and hair may return with different texture or color.

Timeline: What Patients Actually Observe

The sequence below reflects common clinical experience with scalp irradiation. Individual courses vary widely, and fractionation shifts every row.

Phase Approximate timing What happens
Latency Days 0 to 7 No visible change; follicle damage accumulates
Early shedding Weeks 1 to 3 Hair detaches, often patchy within the field
Peak loss Weeks 2 to 4 Maximum loss in treated area
Plateau Treatment end to month 1 Field remains bare or thin
Early regrowth Months 1 to 3 Fine, often depigmented hair emerges
Maturing regrowth Months 3 to 12 Texture and color gradually normalize

A counterintuitive detail: regrowing hair sometimes appears white or gray at first, because melanocytes in the follicle are also radiosensitive and recover more slowly than keratinocytes. Pigment often returns, but not always.

Edge Cases: Location, Technique, and Individual Variation

Radiation alopecia is not one condition. It is a family of outcomes defined by where the beam goes and how it is delivered.

Field location dominates. Whole-brain radiation therapy can thin hair diffusely because the entire scalp is in the field. Stereotactic radiosurgery for a small lesion treats a narrow volume, so hair loss is often a small patch. Breast irradiation usually spares the scalp entirely but can reduce axillary hair on the treated side.

Technique matters. Intensity-modulated radiation therapy and volumetric arc therapy shape dose around target volumes, which can reduce scalp dose during brain treatment when sparing is a priority. Scalp-avoidance techniques exist for whole-brain courses, though they trade some target coverage for follicle protection. Superficial skin treatments such as electron therapy for scalp lesions can produce sharply demarcated patches of loss.

Fraction size and total dose interact. Hypofractionated courses deliver larger daily doses, which raises biologic effect on follicles. That may increase both severity and permanence risk compared with conventional fractionation at the same total.

Individual factors modify expression. Chemotherapy given concurrently or recently can compound follicle injury, since many cytotoxic agents also target anagen matrix cells. Nutritional status, thyroid function, and iron status influence hair cycling broadly. Age alters follicle density and pigmentation but does not reliably predict radiation response.

A professional caveat worth stating plainly: most published dose thresholds come from older series using varied endpoints, definitions, and scoring systems. A clinician estimating permanent alopecia risk from a treatment plan uses plan-specific dosimetry and clinical judgment, not a single number copied from a review.

Misconceptions: What Radiation Hair Loss Is Not

Several beliefs circulate widely and distort expectations.

Radiation is not chemotherapy, and the two cause hair loss differently. Chemotherapy is systemic and typically affects all anagen follicles, producing diffuse shedding including the scalp. Radiation is local, so loss is generally confined to the treated field. A patient receiving pelvic radiation should not expect scalp hair loss.

Radiation alopecia is not always permanent. Many patients regrow hair, especially after lower-dose or fractionated courses. The distinction between temporary and permanent loss is dose and stem-cell survival, not the mere fact of exposure.

Hair loss does not indicate treatment failure or a bad reaction requiring emergency care. It is an expected effect in many head and neck and cranial courses.

Regrowth is not guaranteed to restore original hair. Texture, density, and color can differ permanently after higher doses.

Scattered low-dose exposure is not equivalent to a focused therapeutic dose. Diagnostic imaging delivers doses far below follicle-injury thresholds, which is why routine CT or X-ray does not cause alopecia.

Red-flag warnings that warrant prompt clinical contact:

Sudden diffuse hair loss across the entire scalp during localized treatment, which may suggest another cause such as thyroid disease, iron deficiency, or a medication effect. Scalp redness, blistering, moist desquamation, or severe pain in the treated field, which indicates radiation dermatitis needing management. Hair loss accompanied by new focal neurologic symptoms during cranial treatment. Persistent non-healing scalp wounds or infection signs in a treated area. Unexpected hair loss outside the radiation field.

Practical Actions: What to Do and What to Ask

Practical management starts before the first fraction.

Ask for the scalp dose. Request that your radiation oncologist explain the estimated scalp dose and whether scalp sparing is feasible for your plan. For cranial treatment, scalp-avoidance planning may reduce follicle exposure without compromising the target, but only if the clinical situation allows it.

Treat hair gently during and after treatment. Use a soft brush, avoid tight hairstyles, and minimize heat and chemical treatments on irradiated skin. Gentle handling reduces traction loss on already fragile shafts.

Protect the treated scalp from sun. Irradiated skin is more sensitive to ultraviolet exposure. Hats and sunscreen on intact skin are reasonable, with guidance from your care team about products on treated areas.

Expect the timeline and plan cosmetically. Many patients choose scarves, hats, or wigs during peak loss. Knowing that shedding typically starts within two to three weeks helps with preparation.

Track regrowth objectively. Photograph the area under consistent lighting monthly after treatment ends. Regrowth often begins as fine, pale hair before density and pigment return.

Discuss persistent loss. If no regrowth appears by roughly six months after treatment, ask about evaluation for permanent alopecia and whether any adjunctive options are appropriate for your situation.

The comparison below frames radiation alopecia against other common causes of hair loss, because the distinctions drive what to do next.

Feature Radiation alopecia Chemotherapy alopecia Androgenetic alopecia Telogen effluvium
Distribution Confined to radiation field Diffuse, often whole scalp Patterned, crown and temples Diffuse thinning
Onset 1 to 3 weeks after start 2 to 4 weeks after start Gradual over years Weeks to months after trigger
Mechanism Local follicle cell death Systemic anagen arrest Hormonal follicle miniaturization Cycle shift to shedding
Reversibility Dose-dependent Usually reversible Progressive Usually reversible
Key action Review scalp dosimetry Supportive care Medical evaluation Identify and treat trigger

Limitations: What the Evidence Cannot Settle

Several questions remain genuinely open, and honest explanation requires saying so.

Precise permanent-alopecia thresholds are not standardized. Published ranges vary by study population, endpoint definition, and treatment era. The 5 to 7 Gy single-dose figure is a useful anchor, not a universal cutoff.

Long-term regrowth quality is understudied. Most reports focus on presence or absence of hair rather than density, caliber, and color match. Patients often care about the latter.

Scalp-sparing techniques continue to evolve, and their follicle-protection benefit must be weighed against target coverage. No technique eliminates risk entirely when the scalp is in or near the treatment volume.

Individual susceptibility is poorly characterized. Genetic variation in DNA repair capacity likely modulates follicle response, but validated predictive tests are not in routine use.

What can be said with confidence is the core answer. Radiation causes hair loss when follicles in the beam receive enough dose to injure dividing matrix cells. The loss is usually field-limited and often temporary. Dose, fractionation, location, and stem-cell survival determine the outcome. Patients facing scalp irradiation should ask about scalp dose explicitly, because that number, more than any general statistic, predicts what will happen to their hair.